Uremic Leontiasis Ossea: Distinctive Imaging Features Allow Differentiation From Other Clinical Causes Of Leontiasis Ossea
Jun 02, 2022
For more info. contact tina.xiang@wecistanche.com
A B S T R A C T
Skeletal changes are a common complication in patients with chronic kidney disease and are traditionally labeled as renal osteodystrophy. Uremic leontiasis ossea is a rare and severe form of renal osteodystrophy with characteristic overgrowth of the craniofacial bones. Imaging, particularly computed tomography, is valuable for the diagnosis and management of such rare conditions. Uremic leontiasis ossea has distinctive imaging features with signifcant overgrowth of the jaw and characteristic internal serpiginous tunneling. The recognition of its radiological appearance and abrupt management is essential to avoid its devastating esthetic and functional impairments.
Click here to learn about herba cistanches benefits
Introduction
The term leontiasis was classically used to describe the lion-like facial appearance in leprosy as a result of its cutaneous changes. Later in 1869, the term ossea has been added to leontiasis by Virchow to describe inflammatory hyperostosis of the facial bones. Indeed, leontiasis ossea is a general descriptive term rather than a disease in itself, which is often applied to diffuse craniofacial overgrowth that resembles the lion's face [3]. Such deformity was documented in varieties of medical conditions such as Paget's disease, fibrous dysplasia, and renal osteodystrophy (ROD).In 1953, Cohen et al. first described the facial manifestations in secondary hyperparathyroidism (SHPT) and chronic kidney disease(CKD) as uremic leontiasis ossea (ULO).
Skeletal changes are a common complication in patients with CKD and are traditionally labeled as ROD. However, such patients' groups are also predisposed to other extra-skeletal manifestations for which the Kidney Disease-Improving Global Outcomes (KDIGO) Foundation recommended a broader term, chronic kidney disease-mineral and bone disorder (CKD-MBD). The KDIGO has also recommended that the term ROD be used exclusively to describe changes in bone morphology associated with CKD. Hence, CKD-MBD is a complex systemic disorder consisting of biochemical alterations, bone changes, soft tissue, and vascular calcifications [8. The basic biochemical alterations in CKD-MBD are hyperphosphatemia, hypocalcemia, and decreased activation of vitamin D which eventually lead to SHPT with increased production of parathyroid hormone (PTH).
ULO is a rare and severe form of ROD with characteristic overgrowth of the craniofacial bones. Few cases of ULO are published in the literature, which can be explained by the availability of dialysis, and the abrupt management of SHPT; as biochemical changes are usually diagnosed earlier before the development of skeletal changes. Furthermore, there is a spectrum of skeletal changes caused by SHPT and labeled with different terminologies, for which the exact number of published cases can't be estimated. The practitioners should be aware of the diagnosis and management of this rare condition, as it may result in devastating esthetic and functional impairments. This report aims to explore the role of imaging in ULO and its distinctive imaging features that allow differentiation of other clinical causes of leontiasis ossea. Additionally, the expected complications and treatment strategies will also be discussed.
Case report
A 28-year-old man presented with progressive painless facial swelling over the last seven months. Change in his voice was also documented. His past medical history included end-stage renal disease (ESRD)of undetermined etiology for the last nine years, currently on hemodialysis 3 times per week, severe un-controlled SHPT, and hypertension. The patient denied any history of vision impairment, hearing loss, dyspnea, or dysphagia.
Upon arrival, the patient blood pressure was elevated (161/101 mmHg), and other vital signs were normal. On physical exam, the patient was noted to have a hard, bony craniofacial protrusion, most pronounced along the maxilla. No tenderness was documented. Labs obtained included the following:13.4 mmol/L urea(4.2-7.2), 920 umol/L creatinine (64-115),6 mL/min/1.73m^2 e-GFR,1.65 mmol/L phosphate (0.80-1.45),1714.3 U/L alkaline phosphatase (50-116),2.080 mmol/L calcium (2.100-2.550), and 3012 ng/L PTH.
Computed tomography (CT) of the facial bones was then re-quested to rule out bone tumors. The scout film demonstrates overgrowth of the jaw, in particular the maxilla, with multiple tiny well-defined lucencies in the calvaria (Fig. 1). The axial, coronal, and sagittal CT images show significant overgrowth of the jaw with internal serpiginous tunneling or channeling; found as alternative rings of hypo- and hyperattenuating associated with loss of corticomedullary differentiation (Fig. 2).
The sagittal CT image shows sclerosis of the vertebral end-plates (Fig. 2).
The history of ESRD, biochemical results of SHPT, and the distinctive imaging features in the craniofacial bones are diagnostic of ULO. The patient is currently enrolled on the active transplant waiting list. The SHPT failed to be controlled by medical therapy for which endocrine surgery consultation was requested for possible parathyroidectomy.
Discussion
Generally, the skeletal manifestations in ROD fall into three main patterns: high bone turnover in SHPT, low bone turnover in rickets/osteomalacia, or mixed [121. Although poorly con-trolled SHPTcan be labeled as a key feature of ULO, the exact pathogenesis is still unknown [13]. Furthermore, the predilection of ULO to involve the craniofacial bones is still unclear [14]. Massicotte-Azamiouch et al. describe the morphological changes in ULO as not limited to osseous changes but include soft tissue changes which eventually give the lion-like facial appearance [15].In 2004, Sagliker et al.found 25 patients with CKD, SHPT, severe craniofacial deformities, tumoral tissues in the mouth, fingertips changes, and psychological problems; and they labeled it Sagliker syndrome.
Although ULO is clinically diagnosed, however, imaging allows differentiation from other diseases with similar craniofacial overgrowth. Imaging is also valuable prior to reconstructive surgeries for patients with cosmetic or functional impairments. Furthermore, imaging can be used as a prognostic tool in ULO to confirm improvement in craniofacial deformities following successful management [1]. Cross-sectional imaging studies, primarily CT, with or without three-dimensional (3D) reconstruction is the imaging modality of choice. Magnetic resonance imaging (MRI) can be requested when CT findings are inconclusive. A panoramic radiograph is useful for the assessment of lamina dura which tends to be affected by hyperparathyroidism. As a part of the management of ULO, imaging plays a vital role in the preoperative location of parathyroid adenoma. Ultrasound and99mTc-sestamibi scintigraphy is the imaging techniques of choice for such scenario[18]. Contrast-enhanced CT and MRI can be reserved for failed parathyroidectomy or discordant ultrasound and scintigraphy findings [18]. Four-dimensional (4D) CT is a valuable technique that demonstrates high diagnostic accuracy for parathyroid adenoma localization in particular for indeterminate findings of ultrasound or scintigraphy.
The diagnosis of ULO poses challenges radiologically and pathologically in particular with a lack of history of ESRD and biochemical results of SHPT. Radiologically, the features of ULO are complex as in ROD which can overlap between rickets/osteomalacia and SHPT [20]. Even pathologically, ULO can be interpreted as other causes of craniofacial overgrowth such as fibrous dysplasia [10]. Generally, the findings of osteomalacia on imaging are non-specific and include reduced bone density, loss of cortical definition, and coarsening of the trabecular pattern in addition to Looser zones or pseudofractures; a type of insufficiency fractures [20,21].On the other hand, hyperparathyroidism presents with bone resorption as the most common radiological manifestation. The bone resorption in the skull is best described as a "salt and pepper" appearance caused by multiple lucencies in the background of a sclerotic ground-glass appearance associated with indistinct in-ner and outer tables. Such a ground-glass pattern can be mistaken for fibrous dysplasia, however, in ULO appears to be diffuse with loss of corticomedullary differentiation [10]. Subperiosteal resorption can also be observed in the lamina dura, which is the bone surrounding the tooth sockets. Osteitis fibrosis cystic is another manifestation of hyperparathyroidism that is a result of activation of the osteoclasts and replacement of the bone marrow by vascular and fibrous tissues. Brown tumor is an extreme form of osteitis fibrosa cystica which presents as solitary or multifocal lytic lesions. Osteosclerosis can be also seen in particular during the healing phase with the characteristic increased bone density of the vertebral end-plates (rugger-jersey spine). Significant overgrowth of the jaw with internal serpiginous tunneling or channeling and loss of corticomedullary differentiation are the specific appearances of ULO. The cause of such appearance is still unknown without histopathological explanation [10]. However, Wang et al. reported the serpiginous tunneling or channeling as a zonal pattern with alternative rings of hypo- and hyperattenuating as a result of osteoclastic and osteoblastic activity [23]. Lee et al.reported such a zonal pattern to be related to concentric layers of repetitive cells and trabeculae in addition to blood products surrounding involuted dense brown tumors.
The main differential diagnoses of ULO are Paget's disease and fibrous dysplasia based on clinical findings of craniofacial overgrowth. However, the overgrowth in such conditions tends to be asymmetrical and multifocal as opposite to diffuse symmetrical involvement in ULO. Histopathological confirmation is not necessary as ULO, fibrous dysplasia, and Paget's disease can have similar findings. Hence, the diagnosis of ULO in patients with craniofacial changes depends on clinical findings of ESRD, biochemical results of SHPT, and classical imaging findings. ULO presents clinically with progressive painless massive overgrowth of the craniofacial bones in particular the jaw, widening of the nares, flattening of the nasal bridge, and increased interdental spacing. Be-side its cosmetic effects, the involvement of the craniofacial bones in ULO causes progressive narrowing of the skull base foramina which may result in compressive cranial neuropathy. Sundaram et al. documented bilateral compressive optic neuropathy caused by ULO with spontaneous improvement meant of the visual symptoms following parathyroidectomy 9]. Hearing loss was also previously reported. Furthermore, ULO may result in other functional impairments such as life-threatening upper airway obstruction, nasal breathing, dysarthria, and dysphagia.
There is limited published data on the treatment strategies of ULO which can be medical and surgical. The majority of cases are resistant to medical therapy alone [1]. The surgical strategies aim to treat the primary cause of SHPT, in addition, to attempting to regain the form and function. Lee et al. documented mild improvement or at least stabilization of the facial deformities following parathyroidectomy in their series of 5 patients with ULO[13]. Yang et al. confirmed the prior published results when they retrospectively assessed 6 patients with relief SHPT and improved quality of life after total parathyroidectomy and autotransplantation [27]. Duan et al. documented notable reversible skeletal changes on imaging following parathyroidectomy and autotransplantation in addition to medical therapy[1. However, ULO may have a high biochemical recurrence rate (60%) within 1 year following the surgery [27]. Hence, they concluded, that ULO is not a simple disease with craniofacial malformations but is a severe systemic disease. Furthermore, abnormal levels of PTH after parathyroidectomy can be explained by residual parathyroid tissue which can be ectopic in location and necessitates post-operative99mTc-sestamibi scintigraphy to detect the location as confirmed by prior reported case [24]. Successful resection of such residual promises to normalize the PTH levels [24]. Based on the rarity of such cases, no clear strategies for maxillofacial reconstruction in order to improve the patient's quality of life. Such strategies have to be timely planned to ensure a higher percentage of mature bone within the lesion.
Conclusion
ULO has distinctive imaging features with significant overgrowth of the jaw and characteristic internal serpiginous tunneling. The recognition of its radiological appearance and abrupt management is essential to avoid its devastating esthetic and functional impairments. Long-term follow-up is required for possible recurrence following successful management. The biochemical screening during hemodialysis is vital as abnormal laboratory results can proceed with the skeletal changes which can be used as preventive tools.
----
ROD, renal osteodystrophy; SHPT, secondary hyperparathyroidism; CKD, chronic kidney disease; ULO, uremic leontasis ossea; KDIGO, Kidney Disease-Improving Global Outcomes; CKD-MBD, chronic kidney disease-mineral, and bone disorder: PTH. parathyroid hor-mone; ESRD, end-stage renal disease; CT, Computed tomography;3D, three-dimensional; MRI, Magnetic resonance imaging;4D, four-dimensional.
